Anti-Tumorigenic Effect of a Novel Derivative of 2-Hydroxyoleic Acid and the Endocannabinoid Anandamide on Neuroblastoma Cells
Authors:
- Hana GolanHGHana Golan
- Raphael MechoulamRMRaphael Mechoulam
- Reem SmoumRSReem Smoum
- Efrat Cohen-ZadaECEfrat Cohen-Zada
- Sara Pri-ChenSPSara Pri-Chen
- Sapir WienerSWSapir Wiener
- Igor GrinbergIGIgor Grinberg
- Dekel D. Bar-LevDBDekel D. Bar-Lev
- Christeeneh G. HajCHChristeeneh G. Haj
- Tamar FisherTFTamar Fisher
- Amos TorenATAmos Toren
Open Access
- 29 June 2022
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 10 (7) , 1552
Abstract
Modulation of the endogenous cannabinoid system has been suggested as a potential anticancer strategy. In the search for novel and less toxic therapeutic options, structural modifications of the endocannabinoid anandamide and the synthetic derivative of oleic acid, Minerval (HU-600), were done to obtain 2-hydroxy oleic acid ethanolamide (HU-585), which is an HU-600 derivative with the anandamide side chain. We showed that treatment of SK-N-SH neuroblastoma cells with HU-585 induced a better anti-tumorigenic effect in comparison to HU-600 as evidenced by 3-[4,5-dimethylthiazole-2-yl]-2,5-diphenyltetrazolium bromide assay, colony-forming assay, and migration assay. Moreover, HU-585 demonstrated pro-apoptotic properties shown by increased levels of activated caspase-3 following treatment and a better senescence induction effect in comparison to HU-600, as demonstrated by increased activity of lysosomal β-galactosidase. Finally, we observed that combined treatment of HU-585 with the senolytic drugs ABT-263 in vitro, and ABT-737 in vivo resulted in enhanced anti-proliferative effects and reduced neuroblastoma xenograft growth in comparison to treatment with HU-585 alone. Based on these results, we suggest that HU-585 is a pro-apoptotic and senescence-inducing compound, better than HU-600. Hence, it may be a beneficial option for the treatment of resistant neuroblastoma especially when combined with senolytic drugs that enhance its anti-tumorigenic effects.Keywords
This publication has 60 references indexed in Scilit:
- 2-Hydroxyoleate, a nontoxic membrane binding anticancer drug, induces glioma cell differentiation and autophagyProceedings of the National Academy of Sciences, 2012
- Sphingomyelin and sphingomyelin synthase (SMS) in the malignant transformation of glioma cells and in 2-hydroxyoleic acid therapyProceedings of the National Academy of Sciences, 2011
- Anandamide exerts its antiproliferative actions on cholangiocarcinoma by activation of the GPR55 receptorLaboratory Investigation, 2011
- Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell linesCarcinogenesis, 2010
- The endogenous cannabinoid, anandamide, induces COX-2-dependent cell death in apoptosis-resistant colon cancer cellsInternational Journal of Oncology, 2010
- Minerval induces apoptosis in Jurkat and other cancer cellsJournal of Cellular and Molecular Medicine, 2010
- Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor SuppressorPLOS Biology, 2008
- In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomasProceedings of the National Academy of Sciences, 2008
- Influence of the Membrane Lipid Structure on Signal Processing via G Protein-Coupled ReceptorsMolecular Pharmacology, 2005
- Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid ReceptorScience, 1992